A Randomised Controlled Feasibility Trial of the Mechanisms of the Fertility Enhancing Effect of Lipiodol in Wome
- Conditions
- SubfertilityEndometriosisReproductive Health and Childbirth - Fertility including in vitro fertilisationRenal and Urogenital - Other renal and urogenital disorders
- Registration Number
- ACTRN12621001164886
- Lead Sponsor
- Professor Neil Johnson
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 45
Women of reproductive age (<50 years) and who have a regular cycle that suggests ovulation, who are due to undergo hysterectomy for benign gynaecologcical conditions
Exclusion criteria are:
- Any fibroid larger than 10cm in maximum dimension; (this change was made after 2 participants were recruited and at the initial screening stages of the MoFEEL trial)
- Known Malignancy;
- Known carrier of organism(s) associated with sexually transmitted infection (STI);
- Women scheduled for purely vaginal hysterectomy.
Women will complete our modification of the standardised World Endometriosis Research Foundation Endometriosis Phenome Harmonisation Project (EPHect) patient questionnaire, which is appropriate for any woman with benign gynaecological disease entering a research trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method